Clinical efficacy and safety evaluation of probiotic-assisted chemotherapy in patients with advanced colorectal cancer
10.12173/j.issn.1008-049X.202401114
- VernacularTitle:益生菌辅助化疗对晚期大肠癌患者的临床疗效和安全性评价
- Author:
Fan YE
1
;
Zhuo LI
;
Xing HUANG
;
Zhigang XIAO
Author Information
1. 湖南师范大学附属第一医院(湖南省人民医院)结直肠肛门外科(长沙 410000)
- Keywords:
Advanced colorectal cancer;
Chemotherapy;
Probiotics;
Clinical efficacy;
Safety
- From:
China Pharmacist
2024;27(2):295-301
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy and safety of probiotic-assisted chemotherapy in patients advanced colorectal cancer(CRC).Methods Patients with advanced CRC admitted to the First Affiliated Hospital of Hunan Normal University from March 2022 to March 2023 were enrolled.CRC patients were randomly divided into the test group(Bifidobacterium triple viable capsule,capecitabine+oxaliplatin)and the control group(capecitabine+oxaliplatin)by random number table method.The short-term efficacy(objective response rate and disease control rate),incidence of gastrointestinal adverse reactions,Karnofsky performance status(KPS)score,and serum tumor markers CA72-4,CA19-9 and CEA levels were compared between the two groups.Results A total of 120 patients with CRC were included,including 60 patients in the test group and 60 in the control group.Compared with the control group,the objective remission rate and disease control rate in the testl group were significantly higher(P<0.05).There was no significant difference in the incidence of nausea and acid reflux between the two groups(P>0.05),and the incidences of abdominal pain,bloating,constipation and diarrhea in the test group were significantly lower than those in the control group(P<0.05).There was no significant difference in KPS score,serum CA72-4,serum CA19-9 and serum CEA levels between the two groups before treatment(P>0.05),and after 4 weeks of treatment,the KPS score of the test group was significantly higher than that of the control group(P<0.05),and the serum levels of CA72-4,serum CA19-9 and serum CEA were lower than those of the control group(P<0.05).Conclusion Probiotics-assisted chemotherapy improve the near-term efficacy,reduce gastrointestinal adverse effects,and improve the quality of life in patients with advanced CRC.
